PL2050435T3 - Preparat przeciwkaszlowy - Google Patents
Preparat przeciwkaszlowyInfo
- Publication number
- PL2050435T3 PL2050435T3 PL08167006T PL08167006T PL2050435T3 PL 2050435 T3 PL2050435 T3 PL 2050435T3 PL 08167006 T PL08167006 T PL 08167006T PL 08167006 T PL08167006 T PL 08167006T PL 2050435 T3 PL2050435 T3 PL 2050435T3
- Authority
- PL
- Poland
- Prior art keywords
- cough mixture
- antitussive
- cough
- mixture
- expectorant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102007000521A DE102007000521A1 (de) | 2007-10-18 | 2007-10-18 | Hustenpräparat |
EP08167006A EP2050435B1 (de) | 2007-10-18 | 2008-10-20 | Hustenpräparat |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2050435T3 true PL2050435T3 (pl) | 2011-11-30 |
Family
ID=40347865
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL08167006T PL2050435T3 (pl) | 2007-10-18 | 2008-10-20 | Preparat przeciwkaszlowy |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP2050435B1 (pl) |
AT (1) | ATE510594T1 (pl) |
DE (1) | DE102007000521A1 (pl) |
DK (1) | DK2050435T3 (pl) |
PL (1) | PL2050435T3 (pl) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201014391D0 (en) * | 2010-08-27 | 2010-10-13 | Biocopea Ltd | Drug composition and its use in therapy |
US9314465B2 (en) | 2009-06-16 | 2016-04-19 | Infirst Healthcare Limited | Drug combinations and uses in treating a coughing condition |
GB0910375D0 (en) | 2009-06-16 | 2009-07-29 | Biocopea Ltd | Drug composition and its use in therapy |
US9308211B2 (en) | 2009-06-16 | 2016-04-12 | Infirst Healthcare Limited | Drug combinations and uses in treating a coughing condition |
US10016437B2 (en) | 2009-06-16 | 2018-07-10 | Infirst Healthcare Limited | Drug combinations and uses in treating a coughing condition |
MA35372B1 (fr) * | 2013-01-28 | 2014-09-01 | Univ Moulay Ismail | Formulation avec ingredients naturels contre l'ashme la toux a un effet nettoyant pulmonaire pour les fumeurs |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2676177A (en) | 1949-11-09 | 1954-04-20 | Hoffmann La Roche | Process for the preparation of optically active 3-methoxy-n-methyl morphinans and salts thereof |
EP0100964A3 (de) * | 1982-07-31 | 1984-06-13 | Reifenrath, Rainer, Dr. | Pharmazeutisches Erzeugnis zur Behandlung und Prophylaxe von Infektionen sowie von Husten und obstruktiven Atemwegserkrankungen sowie Verfahren zu seiner Herstellung |
US4552899A (en) * | 1984-04-09 | 1985-11-12 | Analgesic Associates | Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs |
EP0555411A1 (en) | 1990-10-31 | 1993-08-18 | The Procter & Gamble Company | Dextromethorphan antitussive compositions |
US5141961A (en) * | 1991-06-27 | 1992-08-25 | Richrdson-Vicks Inc. | Process for solubilizing difficulty soluble pharmaceutical actives |
US5510389A (en) * | 1994-03-02 | 1996-04-23 | The Procter & Gamble Company | Concentrated acetaminophen solution compositions |
AU1655595A (en) * | 1994-04-29 | 1995-11-09 | Mcneil-Ppc, Inc. | Solid pharmaceutical dosage form containing flavored film coating |
CA2314893C (en) | 1997-12-22 | 2005-09-13 | Euro-Celtique, S.A. | Opioid agonist/antagonist combinations |
US20030118613A1 (en) * | 1999-01-11 | 2003-06-26 | Dobrozsi Douglas Joseph | Compositions having improved delivery of actives |
US6846495B2 (en) * | 1999-01-11 | 2005-01-25 | The Procter & Gamble Company | Compositions having improved delivery of actives |
DE10203104A1 (de) | 2002-01-25 | 2003-08-07 | Boehringer Ingelheim Pharma | Ambroxol für die Behandlung chronischer Schmerzen |
JP2005519923A (ja) * | 2002-02-04 | 2005-07-07 | ファルマシア・コーポレーション | シクロオキシゲナーゼ−2選択的阻害剤ならびに風邪および咳止め薬の組み合わせを用いる風邪および咳の治療ならびにそれらの組成物 |
TR200803299T1 (tr) * | 2005-11-10 | 2008-11-21 | Century Biologicals Private Limited | Solunum yolu rahatsızlıklarını tedavi etmek için kullanılan dengeli bir formülasyon. |
WO2007084331A2 (en) * | 2006-01-12 | 2007-07-26 | Everett Laboratories, Inc. | Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction |
EP1891936A1 (de) * | 2006-08-18 | 2008-02-27 | Losan Pharma GmbH | Gut schluckbare pharmazeutische Zusammensetzung aus einem oder mehreren wirkstoffhaltigen Teilchen ohne unangenehmes Mundgefühl |
-
2007
- 2007-10-18 DE DE102007000521A patent/DE102007000521A1/de not_active Ceased
-
2008
- 2008-10-20 DK DK08167006.9T patent/DK2050435T3/da active
- 2008-10-20 AT AT08167006T patent/ATE510594T1/de active
- 2008-10-20 EP EP08167006A patent/EP2050435B1/de active Active
- 2008-10-20 PL PL08167006T patent/PL2050435T3/pl unknown
Also Published As
Publication number | Publication date |
---|---|
DK2050435T3 (da) | 2011-09-19 |
EP2050435A1 (de) | 2009-04-22 |
ATE510594T1 (de) | 2011-06-15 |
EP2050435B1 (de) | 2011-05-25 |
DE102007000521A1 (de) | 2009-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201300121A1 (ru) | Ингибитор дпп-4 в комбинации с дополнительным противодиабетическим агентом, таблетки, включающие указанные композиции, их применение и способ их получения | |
IL196108A0 (en) | Active agent formulations, methods of making, and methods of use | |
MX2009000507A (es) | Espuma farmaceutica de acidos grasos. | |
WO2008131056A3 (en) | Sustained release monoeximic formulations of opioid and nonopioid analgesics | |
WO2008011595A3 (en) | Hydrophobic abuse deterrent delivery system | |
WO2008131057A3 (en) | Sustained release formulations of opioid and nonopioid analgesics | |
EP2013016B8 (en) | Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery | |
EP2275108A4 (en) | PHARMACEUTICAL PREPARATION COMPRISING A DPP-IV INHIBITOR AND OTHER DIABETES THERAPEUTIC AGENTS IN CONCOMITANT OR COMBINED FORM | |
WO2007092620A3 (en) | Stable formulations, and methods of their preparation and use | |
EP2273975B8 (en) | Pharmaceutical solutions, process of preparation and therapeutic uses | |
WO2010011439A3 (en) | Gip-based mixed agonists for treatment of metabolic disorders and obesity | |
PL2050435T3 (pl) | Preparat przeciwkaszlowy | |
WO2007135193A3 (fr) | Forme pharmaceutique orale multimicroparticulaire a liberation prolongee comprenant des moyens anti-mesusage et resistant a l'alcool | |
MX2011007589A (es) | Tratamiento de un cancer usando una combinacion de bendamustine y un anticuerpo anti-cd20. | |
BR112012003283A2 (pt) | sal farmaceuticamente aceitável de um agente fotossensibilizante anfifílico, composição farmacêutica, produto, kit, uso de um sal farmaceuticamente aceitável de um agente fotossensibilizante anfifílico, e, método de introdução de uma molécula de medicamento no citosol de uma célula em um paciente. | |
GT201200304A (es) | Composiciones farmacéuticas que comprenden hidromorfona y naloxona | |
SG10201408374WA (en) | Therapeutic Combinations Of Theobromine And An Antihistamine | |
MY175764A (en) | Extended-release formulation for reducing the frequency of urination and method of use thereof | |
GB201014391D0 (en) | Drug composition and its use in therapy | |
WO2011002422A3 (en) | Solubility enhancing pharmaceutical formulation | |
MX2012007225A (es) | Composicion farmaceutica que comprende mezcla de solventes y derivado o analogo de vitamina d. | |
WO2011058373A3 (en) | Drug combination with theobromine and its use in therapy | |
UA105944C2 (uk) | Комбінація теоброміну з деконгестантом і її застосування для лікування кашлю | |
AU2007225022A8 (en) | Non-codeine opioid analgesic process and formulations | |
UA105940C2 (uk) | Лікарська комбінація з теоброміном та опіатом і її використання в лікуванні кашлю |